Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

L.A. Daniels, S. Oerlemans, A.D. Krol, C.L. Creutzberg, L.V. van de Poll-Franse

Research output: Contribution to journalArticleScientificpeer-review

6 Downloads (Pure)

Abstract

Background:
Fatigue is a frequent and persistent problem among Hodgkin lymphoma (HL) survivors. We investigated the prevalence of clinically relevant fatigue in HL survivors and the relation between fatigue and anxiety and depression.
Methods:
Fatigue was measured through the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and Fatigue Assessment Scale (FAS). Anxiety and depression were measured with the Hospital Anxiety and Depression Scale. Questionnaires were mailed to 267 HL survivors. Results were compared with a Dutch age-matched normative population.
Results:
Response rate was 68% (median age 46 years, mean time since diagnosis 4.6 years). Prevalence of fatigue was significantly higher among HL survivors than in the norm population (FAS 41% vs 23%, QLQ-C30 43% vs 28%), as were fatigue levels. There was a significant association between fatigue, anxiety and depression. Of the HL survivors with high symptom levels of depression, 97% also reported fatigue. In multivariate analysis, depression was strongly associated with high levels of fatigue and, to a lesser extent, anxiety and comorbidity.
Conclusions:
Prevalence rates of fatigue are significantly higher in HL survivors than in the general population and differences are clinically relevant. Depression and anxiety were strongly associated with high levels of fatigue. Reducing fatigue levels by treatment of depression and anxiety should be further explored.
Keywords: Hodgkin lymphoma; cancer survivors; population based; quality of life; fatigue; anxiety; depression
Original languageEnglish
Pages (from-to)868-874
JournalThe British Journal of Cancer
Volume110
Issue number4
DOIs
Publication statusPublished - 2014

Fingerprint

Hodgkin Disease
Survivors
Comorbidity
Depression
Neoplasms
Multivariate Analysis

Cite this

Daniels, L.A. ; Oerlemans, S. ; Krol, A.D. ; Creutzberg, C.L. ; van de Poll-Franse, L.V. / Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. In: The British Journal of Cancer. 2014 ; Vol. 110, No. 4. pp. 868-874.
@article{a49955a9c85340769ab616c74d9f2bbf,
title = "Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity",
abstract = "Background: Fatigue is a frequent and persistent problem among Hodgkin lymphoma (HL) survivors. We investigated the prevalence of clinically relevant fatigue in HL survivors and the relation between fatigue and anxiety and depression.Methods: Fatigue was measured through the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and Fatigue Assessment Scale (FAS). Anxiety and depression were measured with the Hospital Anxiety and Depression Scale. Questionnaires were mailed to 267 HL survivors. Results were compared with a Dutch age-matched normative population.Results: Response rate was 68{\%} (median age 46 years, mean time since diagnosis 4.6 years). Prevalence of fatigue was significantly higher among HL survivors than in the norm population (FAS 41{\%} vs 23{\%}, QLQ-C30 43{\%} vs 28{\%}), as were fatigue levels. There was a significant association between fatigue, anxiety and depression. Of the HL survivors with high symptom levels of depression, 97{\%} also reported fatigue. In multivariate analysis, depression was strongly associated with high levels of fatigue and, to a lesser extent, anxiety and comorbidity.Conclusions: Prevalence rates of fatigue are significantly higher in HL survivors than in the general population and differences are clinically relevant. Depression and anxiety were strongly associated with high levels of fatigue. Reducing fatigue levels by treatment of depression and anxiety should be further explored.Keywords: Hodgkin lymphoma; cancer survivors; population based; quality of life; fatigue; anxiety; depression",
author = "L.A. Daniels and S. Oerlemans and A.D. Krol and C.L. Creutzberg and {van de Poll-Franse}, L.V.",
year = "2014",
doi = "10.1038/bjc.2013.779",
language = "English",
volume = "110",
pages = "868--874",
journal = "The British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",

}

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. / Daniels, L.A.; Oerlemans, S.; Krol, A.D.; Creutzberg, C.L.; van de Poll-Franse, L.V.

In: The British Journal of Cancer, Vol. 110, No. 4, 2014, p. 868-874.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

AU - Daniels, L.A.

AU - Oerlemans, S.

AU - Krol, A.D.

AU - Creutzberg, C.L.

AU - van de Poll-Franse, L.V.

PY - 2014

Y1 - 2014

N2 - Background: Fatigue is a frequent and persistent problem among Hodgkin lymphoma (HL) survivors. We investigated the prevalence of clinically relevant fatigue in HL survivors and the relation between fatigue and anxiety and depression.Methods: Fatigue was measured through the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and Fatigue Assessment Scale (FAS). Anxiety and depression were measured with the Hospital Anxiety and Depression Scale. Questionnaires were mailed to 267 HL survivors. Results were compared with a Dutch age-matched normative population.Results: Response rate was 68% (median age 46 years, mean time since diagnosis 4.6 years). Prevalence of fatigue was significantly higher among HL survivors than in the norm population (FAS 41% vs 23%, QLQ-C30 43% vs 28%), as were fatigue levels. There was a significant association between fatigue, anxiety and depression. Of the HL survivors with high symptom levels of depression, 97% also reported fatigue. In multivariate analysis, depression was strongly associated with high levels of fatigue and, to a lesser extent, anxiety and comorbidity.Conclusions: Prevalence rates of fatigue are significantly higher in HL survivors than in the general population and differences are clinically relevant. Depression and anxiety were strongly associated with high levels of fatigue. Reducing fatigue levels by treatment of depression and anxiety should be further explored.Keywords: Hodgkin lymphoma; cancer survivors; population based; quality of life; fatigue; anxiety; depression

AB - Background: Fatigue is a frequent and persistent problem among Hodgkin lymphoma (HL) survivors. We investigated the prevalence of clinically relevant fatigue in HL survivors and the relation between fatigue and anxiety and depression.Methods: Fatigue was measured through the generic European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and Fatigue Assessment Scale (FAS). Anxiety and depression were measured with the Hospital Anxiety and Depression Scale. Questionnaires were mailed to 267 HL survivors. Results were compared with a Dutch age-matched normative population.Results: Response rate was 68% (median age 46 years, mean time since diagnosis 4.6 years). Prevalence of fatigue was significantly higher among HL survivors than in the norm population (FAS 41% vs 23%, QLQ-C30 43% vs 28%), as were fatigue levels. There was a significant association between fatigue, anxiety and depression. Of the HL survivors with high symptom levels of depression, 97% also reported fatigue. In multivariate analysis, depression was strongly associated with high levels of fatigue and, to a lesser extent, anxiety and comorbidity.Conclusions: Prevalence rates of fatigue are significantly higher in HL survivors than in the general population and differences are clinically relevant. Depression and anxiety were strongly associated with high levels of fatigue. Reducing fatigue levels by treatment of depression and anxiety should be further explored.Keywords: Hodgkin lymphoma; cancer survivors; population based; quality of life; fatigue; anxiety; depression

U2 - 10.1038/bjc.2013.779

DO - 10.1038/bjc.2013.779

M3 - Article

VL - 110

SP - 868

EP - 874

JO - The British Journal of Cancer

JF - The British Journal of Cancer

SN - 0007-0920

IS - 4

ER -